Literature DB >> 31494835

Early Intervention in Alzheimer's Disease: How Early is Early Enough?

Dong-Yu Fan1,2, Yan-Jiang Wang3,4.   

Abstract

Entities:  

Year:  2019        PMID: 31494835      PMCID: PMC6977799          DOI: 10.1007/s12264-019-00429-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  13 in total

Review 1.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

2.  Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.

Authors:  Eric McDade; Guoqiao Wang; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; David M Holtzman; Nigel J Cairns; Alison M Goate; Daniel S Marcus; John C Morris; Katrina Paumier; Chengjie Xiong; Ricardo Allegri; Sarah B Berman; William Klunk; James Noble; John Ringman; Bernardino Ghetti; Martin Farlow; Reisa A Sperling; Jasmeer Chhatwal; Stephen Salloway; Neill R Graff-Radford; Peter R Schofield; Colin Masters; Martin N Rossor; Nick C Fox; Johannes Levin; Mathias Jucker; Randall J Bateman
Journal:  Neurology       Date:  2018-09-14       Impact factor: 9.910

3.  Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease.

Authors:  David Henley; Nandini Raghavan; Reisa Sperling; Paul Aisen; Rema Raman; Gary Romano
Journal:  N Engl J Med       Date:  2019-04-11       Impact factor: 91.245

4.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

5.  Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.

Authors:  Blaine R Roberts; Monica Lind; Aaron Z Wagen; Alan Rembach; Tony Frugier; Qiao-Xin Li; Timothy M Ryan; Catriona A McLean; James D Doecke; Christopher C Rowe; Victor L Villemagne; Colin L Masters
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

6.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

Review 7.  A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease.

Authors:  Francesco Panza; Bruno P Imbimbo; Madia Lozupone; Giancarlo Logroscino
Journal:  Nat Rev Neurol       Date:  2019-02       Impact factor: 42.937

Review 8.  Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease.

Authors:  Xian-Le Bu; Shu-Sheng Jiao; Yan Lian; Yan-Jiang Wang
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  η-Secretase processing of APP inhibits neuronal activity in the hippocampus.

Authors:  Michael Willem; Sabina Tahirovic; Marc Aurel Busche; Saak V Ovsepian; Magda Chafai; Scherazad Kootar; Daniel Hornburg; Lewis D B Evans; Steven Moore; Anna Daria; Heike Hampel; Veronika Müller; Camilla Giudici; Brigitte Nuscher; Andrea Wenninger-Weinzierl; Elisabeth Kremmer; Michael T Heneka; Dietmar R Thal; Vilmantas Giedraitis; Lars Lannfelt; Ulrike Müller; Frederick J Livesey; Felix Meissner; Jochen Herms; Arthur Konnerth; Hélène Marie; Christian Haass
Journal:  Nature       Date:  2015-08-31       Impact factor: 49.962

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

View more
  10 in total

1.  Combining Multiple Factors to Predict Alzheimer's Disease.

Authors:  Xiao-Lin Gao; Jun Wang; Yan-Jiang Wang; Xian-Le Bu
Journal:  Neurosci Bull       Date:  2022-05-11       Impact factor: 5.271

2.  Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.

Authors:  Chang Chen; Jing Wei; Xiaokuang Ma; Baomei Xia; Neha Shakir; Jessica K Zhang; Le Zhang; Yuehua Cui; Deveroux Ferguson; Shenfeng Qiu; Feng Bai
Journal:  Neurosci Bull       Date:  2022-09-24       Impact factor: 5.271

3.  Naturally-Occurring Antibodies Against Bim are Decreased in Alzheimer's Disease and Attenuate AD-type Pathology in a Mouse Model.

Authors:  Jie-Ming Jian; Dong-Yu Fan; Ding-Yuan Tian; Yuan Cheng; Pu-Yang Sun; Cheng-Rong Tan; Gui-Hua Zeng; Chen-Yang He; Ye-Ran Wang; Jie Zhu; Xiu-Qing Yao; Yan-Jiang Wang; Yu-Hui Liu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

4.  Apolipoprotein E Drives Early Blood-Brain Barrier Damage in Alzheimer's Disease.

Authors:  Qianqian Zhang; Chunming Xie
Journal:  Neurosci Bull       Date:  2020-10-17       Impact factor: 5.203

5.  Targeting the Transnitrosylation Cascade Provides a Novel Therapeutic Strategy for Alzheimer's Disease.

Authors:  Yi Liu; Gang Wu; Xiji Shu; Xiaochuan Wang
Journal:  Neurosci Bull       Date:  2021-05-27       Impact factor: 5.271

Review 6.  Emerging Role of PD-1 in the Central Nervous System and Brain Diseases.

Authors:  Junli Zhao; Alexus Roberts; Zilong Wang; Justin Savage; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2021-04-20       Impact factor: 5.271

7.  Capsaicin consumption reduces brain amyloid-beta generation and attenuates Alzheimer's disease-type pathology and cognitive deficits in APP/PS1 mice.

Authors:  Jun Wang; Bin-Lu Sun; Yang Xiang; Ding-Yuan Tian; Chi Zhu; Wei-Wei Li; Yu-Hui Liu; Xian-Le Bu; Lin-Lin Shen; Wang-Sheng Jin; Zhen Wang; Gui-Hua Zeng; Wei Xu; Li-Yong Chen; Xiao-Wei Chen; Zhian Hu; Zhi-Ming Zhu; Weihong Song; Hua-Dong Zhou; Jin-Tai Yu; Yan-Jiang Wang
Journal:  Transl Psychiatry       Date:  2020-07-13       Impact factor: 6.222

8.  Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.

Authors:  Ju Wang; Hui-Jie Hu; Zi-Kai Liu; Jing-Jing Liu; Shan-Shan Wang; Qing Cheng; Hong-Zhuan Chen; Mingke Song
Journal:  Transl Neurodegener       Date:  2021-03-31       Impact factor: 8.014

Review 9.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives.

Authors:  Bin-Lu Sun; Yang Chen; Dong-Yu Fan; Chi Zhu; Fan Zeng; Yan-Jiang Wang
Journal:  Sci China Life Sci       Date:  2020-10-23       Impact factor: 6.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.